Knott David M Jr Travere Therapeutics, Inc. Transaction History
Knott David M Jr
- $173 Million
- Q4 2024
A detailed history of Knott David M Jr transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Knott David M Jr holds 228,000 shares of TVTX stock, worth $5.01 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
228,000
Previous 258,231
11.71%
Holding current value
$5.01 Million
Previous $3.61 Million
9.91%
% of portfolio
2.29%
Previous 1.27%
Shares
6 transactions
Others Institutions Holding TVTX
# of Institutions
213Shares Held
94.1MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$168 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$162 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$148 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$109 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$93.6 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.41B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...